NexGel Inc. (NXGLW)
NASDAQ (CM) NASDAQ (CM) Primary Summary
NexGel Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Anthony Scaramucci SkyBridge Capital II LLC | 550,000 | $244,999.72 | $15,070 | -$229,929.72 | -93.85% |
| BO Brian Oliveira Clear Street Group Inc. | 50,614 | $15,179.01 | $1,386.82 | -$13,792.19 | -90.86% |
NexGel Inc. (NXGLW) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has NexGel Inc. ever had a stock split?
NexGel Inc. Profile
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Adam R. Levy CEO | NASDAQ (CM) Exchange | 65344E115 CUSIP |
| US Country | 19 Employees | - Last Dividend | - Last Split | 22 Dec 2021 IPO Date |
Overview
NEXGEL, Inc. specializes in the production of high-water content, electron beam cross-linked, and aqueous polymer hydrogels and gels, catering to a variety of industries including wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company, originally founded as AquaMed Technologies, Inc., underwent a name change to NEXGEL, Inc. in November 2019, reflecting its evolved focus and commitment to innovation in hydrogel technology. Established in 2009 and operating from Langhorne, Pennsylvania, NEXGEL has positioned itself as a key player in the hydrogel product market by leveraging its expertise in polymer science to create products that meet the specific needs of its customers across different sectors.
Products and Services
- Wound Care:
NEXGEL's hydrogels are used in advanced wound care products. Their high water content promotes a moist healing environment, which is conducive to wound healing, making them ideal for the treatment of burns, ulcers, and other chronic wounds. These products are designed to alleviate pain, promote faster healing, and reduce the risk of infection.
- Medical Diagnostics:
The company’s hydrogel technology is also applied in the field of medical diagnostics. Their products serve as conductive mediums in diagnostic patches and electrodes, enhancing the accuracy and efficiency of various medical tests and procedures. This application underlines the versatility and reliability of NEXGEL's hydrogel formulations in critical healthcare applications.
- Transdermal Drug Delivery:
NEXGEL's hydrogels are engineered to serve as vehicles for transdermal drug delivery systems. These gels enable controlled release of medication through the skin, providing an effective, non-invasive method for drug administration. This technology is pivotal for patients requiring continuous medication delivery, maximizing therapeutic effectiveness while minimizing side effects.
- Cosmetics:
Within the cosmetics industry, NEXGEL's products find their application in various skincare and beauty products. The hydrogels' properties, such as their cooling effect and ability to deliver active ingredients effectively to the skin, make them a popular choice in formulating products like moisturizers, masks, and patches that aim to hydrate, rejuvenate, and treat the skin.
